Clinical Trials Sponsored by Philips Healthcare

Total 4926 results

Philipp Schuetz

Recruiting

Effect of Continued Nutritional Support at Hospital Discharge on Mortality, Frailty, Functional Outcomes and Recovery (EFFORT II)

Malnutrition

Switzerland
Philips Clinical & Medical Affairs Global
NAMSA

Not yet recruiting

The THOR IDE Study (THOR)

Peripheral Artery Disease | PAD | Peripheral Artery Stenosis | Peripheral Artery Calcification
Universitaire Ziekenhuizen KU Leuven
Philips Respironics

Recruiting

Belgian Central Sleep Apnea REgistry (B-CARE)

Central Sleep Apnea

Belgium
University of Michigan
Philips Health Care

Terminated

Refinement and Assessment of New MRI Technologies for Cardiovascular Exams Using the Phillips CMR Patch

Cardiomyopathies

United States
University of Pennsylvania
Philips Medical Systems

Completed

Testing Automated Echocardiography

This Study is Being Conducted to Collect Echocardiographic Data to Test the Lumify Ultrasound With Hemodynamic Automation Device

United States
Children's Hospital of Philadelphia
Philips Respironics

Completed

Evaluation of Adherence and Therapeutic Effectiveness of Bi-Flex Versus CPAP in Children With OSA

Obstructive Sleep Apnea

United States
Wissenschaftliches Institut Bethanien e.V
Philips Respironics

Completed

Effect of Positive Airway Pressure Therapy on Hospitalization and Mortality in SDB Patients With Comorbid Chronic Obstructive Pulmonary Disease (COPD) or/and Heart Failure (HF)

Heart Failure | Pulmonary Disease, Chronic Obstructive | Sleep-Disordered Breathing

Germany, Denmark, France
Karolinska University Hospital
Philips Medical Systems

Completed

Image Quality and Radiation Dose in Angiography

Arteriovenous Malformations | Aneurysm | Stenosis | Dural Arteriovenous Malformations

Sweden
University of British Columbia
Philips Respironics

Completed

Use of a Remote-Monitoring System to Diagnose and Treat Obstructive Sleep Apnea

Obstructive Sleep Apnea-hypopnea

Canada
Maxima Medical Center
Philips Research Europe

Completed

Rheumatoid Arthritis Disease Activity Monitor (RADAM)

Rheumatoid Arthritis

Netherlands
Jane Phillips Medical Center

Withdrawn

Local Paclitaxel Delivery to Prevent Restenosis in Peripheral Arterial Disease (ResTAP)

Peripheral Arterial Disease | Restenosis
Philips Electronics Nederland B.V. acting through...
Factory CRO; Research America Inc; Qserve

Completed

Psychometric Properties of IntelliSpace Cognition

Cognitive Functioning of Healthy Individuals

United States
Philip Morris Products S.A.

Recruiting

Effect of Switching From Cigarette Smoking to THS on Disease Progression in Mild to Moderate COPD Subjects With Chronic Bronchitis Symptoms.

Smoking | Tobacco Use | COPD

United States, Bulgaria, Czechia, Germany, Japan, Romania, Slovakia, United Kingdom
Philip Morris Products S.A.

Completed

Reduction of Exposure, Inflammation, and Oxidative Stress Following at Least 2 Years of Switching to THS Use Compared to Cigarette Smoking

Smoking | Inflammation | Oxidative Stress | Smoking Abstinence

Japan, Germany, Czechia, Greece
Philip Morris Products S.A.

Completed

Reduced HPHC Exposure in Cigarette Smokers Switching to P4M3 Gen. 2.0 Compared to Continuing Smoking, or Smoking Abstinence

Nicotine | Nicotine Vaping | Vaping

United Kingdom
Philip Morris Products S.A.

Terminated

Cross-Sectional Survey on the Use of Tobacco Products - Italy

Tobacco Use

Switzerland
Philip Morris Products S.A.

Active, not recruiting

Pharmacokinetics and Comparative Bioavailability of Nicotine From Two Variants of NP2, NP2-4mg and NP2-6mg, Compared to Nicotine Lozenge 4mg (Loz-4mg) and Nicotine Gum 4mg (Gum-4mg)

Tobacco Use

Canada
Philip Morris Products S.A.

Completed

Comparison of Abdominal Aortic Aneurysm Growth in Adult Smoking Patients Who Either Switch to IQOS, Continue Smoking, or Quit Smoking.

Smoking | Abdominal Aortic Aneurysm | IQOS Use

Japan
Philip Morris Products S.A.

Completed

A Smoking Cessation Study to Understand the Biological and Functional Changes After One Year of Smoking Cessation (RIBESC)

Cigarette Smoking

United States, Poland, Germany, Japan, United Kingdom
Philip Morris Products S.A.

Completed

Nicotine Pharmacokinetics and Subjective Effects of Nicotine Pouch 1.0 Compared to Velo® Ice Cool and Zyn® Cool Mint Mini Dry in Healthy Smokers

Smoking | Nicotine

United Kingdom
Philip Grant

Withdrawn

Effect of Reducing Nucleotide Exposure on Bone Health (ReNew) (ReNew)

HIV/AIDS | Osteopenia | HIV-1-infection

United States
Philip Morris Products S.A.

Completed

Product Use and Adaptation, Safety and Tolerability of P3P in Adult Healthy Smokers Switching to it

Pharmacokinetics

Russian Federation
Philip Morris Products S.A.

Completed

Nicotine Pharmacokinetic Profile of the CHTP 1.1 M

Smoking

Japan
Philip Morris Products S.A.

Completed

Reduced Exposure Study Using THS 2.2 Menthol With 5 Days in a Confinement Setting and 85 Days in an Ambulatory Setting

Smoking

Japan
Philip Morris Products S.A.

Completed

Nicotine Pharmacokinetic Profile and Safety of the Tobacco Heating System 2.2 Menthol (THS 2.2 Menthol).

Smoking

Japan
Philip Morris Products S.A.

Completed

Nicotine Pharmacokinetic Profile and Safety of the Tobacco Heating System 2.2 Menthol (THS 2.2 Menthol)

Smoking

United States
Philip Morris Products S.A.

Completed

Reduced Exposure Study in Smokers Using THS 2.2 With 5 Days in a Confinement Setting.

Smoking

Poland
Philip Morris Products S.A.

Completed

European Exposure Study

Smoking

United Kingdom
Philip Morris Products S.A.

Completed

User Acceptability of a Nicotine Lactate Delivery System (P3L)

Smoking

United States
Philip Morris Products S.A.

Unknown

Japanese Post-Market Cohort Study

Smoking | Tobacco Product

Japan
Philip Morris Products S.A.

Completed

Nicotine Pharmacokinetic Profile and Safety of the Tobacco Heating System 2.2 (THS 2.2)

Smoking

Japan
Beth Israel Deaconess Medical Center
Boston Scientific Corporation; Medtronic; Philips Healthcare; Bard Peripheral Vascular... and other collaborators

Active, not recruiting

Safety Assessment of Femoropopliteal Endovascular Treatment With PAclitaxel-coated Devices (SAFE-PAD Study) (SAFE-PAD)

Peripheral Arterial Disease | Safety Issues | Paclitaxel Adverse Reaction

United States
Philip Morris Products S.A.

Terminated

Cross-Sectional Survey on the Use of Tobacco Products - Germany

Tobacco Use

Switzerland
Philip Morris Products S.A.

Completed

Nicotine Pharmacokinetics of THS Single Use of a Regular or a Menthol Stick Compared to CIG

Smoking, Tobacco

United Kingdom
Philip Morris Products S.A.

Completed

Reduced Exposure Study Using the CHTP 1.2 With 5 Days in a Confinement Setting Followed by 85 Days in an Ambulatory Setting.

Smoking

Poland
Philip Morris Products S.A.

Completed

Effect of Switching From Cigarette Smoking to IQOS on Exercise Capacity

Smoking | Exercise Capacity

Germany
Philip Morris Products S.A.

Completed

Reduced Exposure Study Using THS 2.2 Menthol With 5 Days in a Confinement Setting Followed by 86 Days in an Ambulatory Setting

Smoking

United States
Philip Morris Products S.A.

Completed

Reduced Exposure Study in Smokers Using the Tobacco Heating System 2.2 (THS 2.2) for 5 Days in a Confinement Setting

Smoking

Japan
Philip Morris Products S.A.

Completed

Nicotine Pharmacokinetics and Pharmacodynamics, Safety and Tolerability of P3P

Pharmacokinetics

Switzerland
Philip Morris Products S.A.

Completed

Study to Investigate the Nicotine Pharmacokinetic Profiles and Pharmacodynamic Effects of P4M3 Variants

Vaping | Nicotine Absorption

United States
Philip Morris Products S.A.

Completed

Exploratory THS 2.1 Biomarkers of Exposure Study (ZRHX-EX-01)

Smoking

Poland
Philip Morris Products S.A.

Completed

Exploratory THS 2.1 Nicotine Pharmacokinetics and Safety Study

Smoking

United Kingdom
Philip Morris Products S.A.

Completed

Smoking Research Study

Smoking | Non-smoking

United Kingdom
Catharina Ziekenhuis Eindhoven
Philips Electronics Nederland B.V. acting through Philips CTO organization; Eindhoven University of Technology

Unknown

TraceBook: the Clinical Proof of Concept on the Intensive Care. (TraceBook)

Critical Illness | Safety Issues

Netherlands
Philip Morris Products S.A.

Completed

Nicotine Pharmacokinetics Following Use of the P4M3 Gen 2.0 E-Cigarette Compared to Smoking Cigarettes

Nicotine | Nicotine Vaping | Vaping

United States
Philip Morris Products S.A.

Terminated

Cross-Sectional Survey on the Use of Tobacco Products - London (UK)

Tobacco Use

Switzerland
Philip Morris Products S.A.

Completed

Reduced Exposure to HPHC in Smokers Switching From Cigarettes to Different Versions of THS

Smoking | Tobacco Use | Tobacco Smoking

United Kingdom
Philip Morris Products S.A.

Withdrawn

Effect of Switching From Cigarette Smoking to THS on Systemic Endothelial Function in Subjects With Established Atherosclerotic Disease

Cardiovascular Diseases | Coronary Artery Disease | Smoking | Peripheral Arterial Disease | Tobacco Use
Philip Morris Products S.A.

Completed

Reduced Exposure Study Using CHTP 1.0 During 5 Days in Confinement.

Smoking

Poland
Philip Morris Products S.A.

Completed

Effect of Switching From Cigarette Smoking to the Use of IQOS on Periodontitis Treatment Outcome

Periodontal Diseases | Gingival Diseases | Chronic Periodontitis | Smoking, Cigarette | Periodontal Pocket | Tooth Mobility

Japan

Clinical Trials Sponsored by Philips Healthcare

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Romania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations